| 000 | 00744 a2200217 4500 | ||
|---|---|---|---|
| 005 | 20250517055836.0 | ||
| 264 | 0 | _c20151201 | |
| 008 | 201512s 0 0 fre d | ||
| 022 | _a0047-2166 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVan Genechten, Dana | |
| 245 | 0 | 0 |
_a[Brimonidine (Mirvaso), dermal use]. _h[electronic resource] |
| 260 |
_bJournal de pharmacie de Belgique _cJun 2015 |
||
| 300 |
_a45-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdrenergic alpha-2 Receptor Agonists _xadministration & dosage |
| 650 | 0 | 4 |
_aBrimonidine Tartrate _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aRosacea _xdrug therapy |
| 773 | 0 |
_tJournal de pharmacie de Belgique _gno. 2 _gp. 45-6 |
|
| 999 |
_c25353657 _d25353657 |
||